These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 19549288
1. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Buchanan E, Gaunt WW, Cardigan T, Garrick V, McGrogan P, Russell RK. Aliment Pharmacol Ther; 2009 Sep 01; 30(5):501-7. PubMed ID: 19549288 [Abstract] [Full Text] [Related]
2. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. J Gastroenterol Hepatol; 2006 Oct 01; 21(10):1609-14. PubMed ID: 16928225 [Abstract] [Full Text] [Related]
3. [Therapeutic effects of combined enteral nutrition with Tripterygium Wilfordii poly-glycoside in remission induction of active adult Crohn's disease]. Gong JF, Niu LY, Wei XW, Zhu WM, Li N, Li JS. Zhonghua Wai Ke Za Zhi; 2009 Aug 15; 47(16):1213-7. PubMed ID: 19781164 [Abstract] [Full Text] [Related]
4. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Rubio A, Pigneur B, Garnier-Lengliné H, Talbotec C, Schmitz J, Canioni D, Goulet O, Ruemmele FM. Aliment Pharmacol Ther; 2011 Jun 15; 33(12):1332-9. PubMed ID: 21507029 [Abstract] [Full Text] [Related]
5. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease. Cameron FL, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, Buchanan E, Barclay AR, McGrogan P, Russell RK. Aliment Pharmacol Ther; 2013 Mar 15; 37(6):622-9. PubMed ID: 23360085 [Abstract] [Full Text] [Related]
6. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May 15; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
7. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease. Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A. BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458 [Abstract] [Full Text] [Related]
8. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM. Aliment Pharmacol Ther; 2004 Jul 15; 20(2):167-72. PubMed ID: 15233696 [Abstract] [Full Text] [Related]
9. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse. Gerasimidis K, Nikolaou CK, Edwards CA, McGrogan P. J Clin Gastroenterol; 2011 Mar 15; 45(3):234-9. PubMed ID: 20871409 [Abstract] [Full Text] [Related]
10. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease. Zhou S, Huang Z, Hou W, Lin Y, Yu J. Inflamm Res; 2024 Feb 15; 73(2):199-209. PubMed ID: 38168701 [Abstract] [Full Text] [Related]
11. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome. Frivolt K, Schwerd T, Werkstetter KJ, Schwarzer A, Schatz SB, Bufler P, Koletzko S. Aliment Pharmacol Ther; 2014 Jun 15; 39(12):1398-407. PubMed ID: 24779671 [Abstract] [Full Text] [Related]
12. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. Grover Z, Muir R, Lewindon P. J Gastroenterol; 2014 Apr 15; 49(4):638-45. PubMed ID: 23636735 [Abstract] [Full Text] [Related]
13. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands. de Bie C, Kindermann A, Escher J. J Crohns Colitis; 2013 May 15; 7(4):263-70. PubMed ID: 22820027 [Abstract] [Full Text] [Related]
14. Serum concentrations of VEGF and TGF-β1 during exclusive enteral nutrition in IBD. Wedrychowicz A, Kowalska-Duplaga K, Jedynak-Wasowicz U, Pieczarkowski S, Sladek M, Tomasik P, Fyderek K. J Pediatr Gastroenterol Nutr; 2011 Aug 15; 53(2):150-5. PubMed ID: 21788755 [Abstract] [Full Text] [Related]
15. Influence of exclusive enteral nutrition therapy on bone density and geometry in newly diagnosed pediatric Crohn's disease patients. Werkstetter KJ, Schatz SB, Alberer M, Filipiak-Pittroff B, Koletzko S. Ann Nutr Metab; 2013 Aug 15; 63(1-2):10-6. PubMed ID: 23867548 [Abstract] [Full Text] [Related]
16. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease. Guo Z, Wu R, Zhu W, Gong J, Zhang W, Li Y, Gu L, Li N, Li J. Nutr Clin Pract; 2013 Aug 15; 28(4):499-505. PubMed ID: 23851180 [Abstract] [Full Text] [Related]
17. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study. Urlep D, Benedik E, Brecelj J, Orel R. Eur J Pediatr; 2020 Mar 15; 179(3):431-438. PubMed ID: 31781933 [Abstract] [Full Text] [Related]